Skip to content
Back to announcement

20230731_INAF_Laporan Informasi dan Fakta Material_31356353_lamp2.pdf

Financial statement Text extracted INAF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1 OCR 0.862
(,

SURAT PERNYATAAN DIREKSI DIRECTORS' STATEMENT LETTER
TENTANG TANGGUNG JAWAB ATAS REGARDING THE RESPONSIBILITY
LAPORAN KEUANGAN KONSOLIDASIAN FOR THE CONSOLIDATED FINANCIAL STATEMENTS AS
PER 30 JUNI 2023 DAN 31 DESEMBER 2022 AT JUNE 30, 2023 AND DECEMBER 31, 2022
SERTA PERIODE YANG BERAKHIR AND FOR THE PERIOD ENDED
30 JUNI 2023 DAN 2022 JUNE 30, 2023 AND 2022
PT INDOFARMA TBK DAN ENTITAS ANAK PT INDOFARMA TBK AND ITS SUBSIDIARIES
Kami yang bertanda tangan di bawah ini: We, the undersigned :
Nama 5 Agus Heru Darjono : Name
Alamat Kantor : Jl. Indofarma No. 1, Cikarang Barat 17530 8 Official Address
NIK 3201022208700002 $ ID Number
Jabatan 3 Direktur Utama / President Director & Position
Nama : Ariesta Krisnawan . : Name
Alamat Kantor Jl. Indofarma No. 1, Cikarang Barat 17530 5 Official Address
NIK 5204081504670001 i ID Number
Jabatan 5 Direktur Keuangan, Manajemen Risiko dan Sumber Daya Manusia / : Position
Finance, Risk Management and HR Director
Menyatakan bahwa : State that :

1. Kami bertanggung jawab atas penyusunan dan penyajian — /. We are responsible for preparation and presentation of

laporan keuangan konsolidasian PT Indofarma Tbk: Ihe consolidated financial statements of PT Indofarma
Tok:

2. Laporan keuangan konsolidasian PT Indofarma Tbk 2. The consolidated financial — statements — of
telah disusun dan disajikan sesuai dengan Standar PT Indofarma Tbk have been prepared and presented
Akuntansi Keuangan di Indonesia: in accordance with Indonesian Financial Accounting

Standards:

3. a. Semua informasi dalam laporan keuangan 3 4 AJ information contained in the consolidated
konsolidasi PT Indofarma Tbk telah dimuat secara financial statemenis of PT Indofarma Tbk is
lengkap dan benar, #15 complete and correct:

b. Laporan keuangan konsolidasi PT Indofarma Tbk b. The consolidated financial  statemenis of
tidak mengandung informasi atau fakta material PT Indofarma Tbk do not contain misleading
yang tidak benar, dan tidak menghilangkan material information or facis, and do not omit
informasi atau fakta material: material information and facts:

4. Kami bertanggung jawab atas sistem pengendalian 4 We are responsible for the internal control system oj
internal dalam PT Indofarma Tbk. — PTindofrna Tbk £ Dean af

Demikian pernyataan ini dibuat dengan sebenarnya. This statement letter is made truthfully.

Jakarta, 31 Juli 2023/ July 31, 2023
PT Indofarma Tbk

Direktur Utama Direktur Keuangan, Manajemen Risiko dan SDM
/ President Director (Finance, Risk Management and HR Director

Agus Heru Darjono Ariesta Krisnawan (3
PT Indofarma Tbk
Jl. Indofarma No.I Cikarang Barat Ph. 6
Bekasi 17530 — Indonesia Fx. 6.

21-8832 3971/75 Email : headoffice@indofarma.id
21-8832 3972/73 www.indofarma id

File

File Open PDF
Source IDX
Size0.23 MB
Published31 Jul 2023
Pages1
Characters2,739
Text sourceOCR
OCR confidence0.862

Names mentioned 0 people and organisations named in the text · linked when the evidence is strong

The name pass has not read this document yet.

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

↑↓ select ↵ open ⇧↵ see every result